Abstract
Adalimumab plus methotrexate improved SF-36 scores and reduced the effect of rheumatoid arthritis (RA) on work activity for patients with early RA.
Miriam Kimel, Mary Cifaldi, Naijun Chen and Dennis Revicki
The Journal of Rheumatology February 2008, 35 (2) 206-215;
Miriam Kimel
Mary Cifaldi
Naijun Chen
In this issue
Adalimumab plus methotrexate improved SF-36 scores and reduced the effect of rheumatoid arthritis (RA) on work activity for patients with early RA.
Miriam Kimel, Mary Cifaldi, Naijun Chen, Dennis Revicki
The Journal of Rheumatology Feb 2008, 35 (2) 206-215;